Intravitreal Ranibizumab in daily clinical practice for age-related macular degeneration.

被引:0
|
作者
Gozlan, Julien [1 ]
Cazet-Supervielle, Agathe [1 ]
Rouissi, Sahbi [1 ]
De Beketch, Chloe [1 ]
Boissonnot, Michele [1 ]
Leveziel, Nicolas [1 ]
机构
[1] Univ Hosp Poitiers, Ophthalmol, Poitiers, France
关键词
412 age-related macular degeneration; 688; retina;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3888
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life
    Cazet-Supervielle, Agathe
    Gozlan, Julien
    Cabasson, Severin
    Boissonnot, Michele
    Manic, Helene
    Leveziel, Nicolas
    OPHTHALMOLOGICA, 2015, 234 (01) : 26 - 32
  • [2] Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Folk, James C.
    Stone, Edwin M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17): : 1648 - 1655
  • [3] Long-Term Outcomes Of Intravitreal Ranibizumab In Patients With Neovascular Age-Related Macular Degeneration. Besides Clinical Trials
    Juan Escobar, Jose
    Gallego, Roberto
    Romero, Beatriz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
    Karagiannis, Dimitrios A.
    Ladas, Ioannis D.
    Parikakis, Efstratios
    Georgalas, Ilias
    Kotsolis, Athanasios
    Amariotakis, Giorgos
    Soumplis, Vasileios
    Mitropoulos, Panagiotis
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 457 - 461
  • [5] CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The LUMIERE Study
    Cohen, Salomon Y.
    Mimoun, Gerard
    Oubraham, Hassiba
    Zourdani, Alain
    Malbrel, Christian
    Quere, Stephane
    Schneider, Veronique
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03): : 474 - 481
  • [6] CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The TWIN Study
    Souied, Eric H.
    Oubraham, Hassiba
    Mimoun, Gerard
    Cohen, Salomon Y.
    Quere, Stephane
    Derveloy, Audrey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1743 - 1749
  • [7] Intravitreal Bevacizumab for Exudative Age-Related Macular Degeneration in Clinical Practice
    Jonas, Jost B.
    Tao, Yong
    Schlichtenbrede, Frank C.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (05) : 467 - 470
  • [8] Long-term results of intravitreal ranibizumab treatment for neovascular age-related macular degeneration in clinical practice
    Arias, Luis
    EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (01) : 37 - 40
  • [9] Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes
    Meidong Zhu
    Jamie K. Chew
    Geoffrey K. Broadhead
    Kehui Luo
    Nichole Joachim
    Thomas Hong
    Adil Syed
    Andrew A. Chang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1217 - 1225
  • [10] Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes
    Zhu, Meidong
    Chew, Jamie K.
    Broadhead, Geoffrey K.
    Luo, Kehui
    Joachim, Nichole
    Hong, Thomas
    Syed, Adil
    Chang, Andrew A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (08) : 1217 - 1225